EZqure Device Treats a Variety of Chronic Ulcers

​

The EZqure Device intended use - treatment of chronic non-healing wounds such as:  

• Diabetic Wounds.

• Vascular (Arterial or Venous) Leg Ulcers.

• Pressure (Decubitus) Wounds.

• Other Ulcers / Wounds, which are resistance to standard or more complex treatments.
   

EZqure Device demonstrates Well-Established Practical & Clinical Benefits
 

The EZqure Device offers a proven non-invasive electrotherapy option for the acceleration of healing and rapid closure of chronic wounds.

• The EZqure Device is clinically approved for hospitals, clinics and home care.

• The EZqure Device is used for only 90 minutes a day.

• The EZqure Device is easily applied by the caregiver or patient.

• The EZqure Device facilitates complete closure of most hard-to-heal wounds (which are resistant to standard or advanced wound care) within the average period of 6 to 12 weeks [1].

• The EZqure Device is the only clinically available electrotherapy which is based on a novel bioelectrical signal discovered in humans.

• The EZqure Device is the only clinically available electrotherapy with proven therapeutic effectiveness in a Randomized Placebo Controlled Trial – RCT [2].

• The EZqure Device significantly reduces the hospitalization period and treatment costs of non-healing chronic wounds.
   

The EZqure Device triggers a wound healing process which has the following effects:​

• Wound Healing - Initiation and acceleration of the wound healing process.

• Pain - Reduction of local pain.

• Tissue viability - Significant increase in:
  1. Granulation – regeneration of viable connective tissue.
  2. Epithelialization – regeneration of viable epithelial tissue.
  3. Vascularization (angiogenesis) – regeneration of vital blood vessels.